SPECTROSCOPY FOR MEDICAL DIAGNOSIS 3 9 7 6A N A LY T I C A L C H E M I S T R Y / J U N E 1 , 2 0 0 7 will be different. How different they are depends on which tissue types are being compared. Often the spectra of the two populations look very similar to the naked eye, and many research hours have been poured into mathematically deconvoluting and giving clinical meaning to those spectra.To set up a model for a tissue comparison, researchers might start with a mixture of tissue samples that have been classified (e.g., cancerous vs noncancerous) by the gold standard of histopathology. They would take spectra of all those samples and apply one of several statistical methods to extract the subtle spectroscopic differences between the two classes of tissue. These differences are written into an algorithm that can then be used to classify an unknown tissue sample.One of the hottest areas of research in tissue Raman is identifying cancerous versus noncancerous tissue from the brain, cervix, bladder, and other organs ( Figure 1). Most of the work to date has been ex vivo, but Raman researchers say that their ultimate goal is to move into the body. "The direct advantage of Raman is that you don't need to do anything with your tissue," says Gerwin Puppels of Erasmus University Medical Center (The Netherlands). "The only thing you do is shine light on the tissue and collect the light that comes back," he adds; this makes Raman nondestructive and safe to use on real patients.One application could be the use of Raman during surgery to identify the margins of a tumor. Today, surgeons often walk a fine line in deciding how much tissue to remove. Remove too much and they may damage the organ; remove too little and the tumor may recur, necessitating more surgery. A biopsy can take hours or days, whereas Raman could give an answer in seconds.It's not only soft tissue that can be classified by Raman spectroscopy. Bone and tooth enamel have relatively strong Raman signals, and both are receiving attention from scientists in the tissue Raman community. Currently, the risk of osteoporotic bone fracture is assessed by a technique called dual-energy X-ray absorptiometry (DXA), which measures absorption of X-rays by calcium. According to Michael Morris of the University of Michigan, only 50 -70% of the fracture risk is predicted by DXA. What DXA doesn't measure is "bone quality", a general term that includes the chemical makeup of bone.Morris and colleagues use Raman to detect the minerals and collagen fibrils that make up bone. "What we bring to the table are very clear and very unambiguous measurements of bone chemistry that include cross-linking [of collagen] and measures of mineral maturity," Morris says. They have found a clear correlation between bone chemistry and osteoporotic fracture risk ex vivo (2), and they say that they will be moving their studies in vivo shortly.Meanwhile, other researchers are interested in the oral health applications of Raman spectroscopy. "Dental is one area that has been overlooked quite a lot," says...